|
ANTICOAGULANT EFFECT IS INCREASED OF ORAL ANTICOAGULANTS
|
ANTICOAGULANT EFFECT IS INCREASED OF ORAL ANTICOAGULANTS
|
ANTICOAGULANT EFFECT IS INCREASED OF ORAL ANTICOAGULANTS
|
ANTICOAGULANT EFFECT IS INCREASED OF ORAL ANTICOAGULANTS
|
ANTICOAGULANT EFFECT IS INCREASED OF ORAL ANTICOAGULANTS
|
ANTICOAGULANT EFFECT IS INCREASED OF ORAL ANTICOAGULANTS
|
ANTICOAGULANT EFFECT IS INCREASED OF ORAL ANTICOAGULANTS
|
RIFAMPICIN MAY ACCELERATES METABOLISM OF THE DRUG & MAY CAUSE DECREASED PLASMA CONCENTRATION
|
DISULFIRAM REDUCES ITS PLASMA CLEARANCE BY 85%
|
DISULFIRAM CAUSES ACUTE PSYCHOSIS
|
DISULFIRAM CAUSES ACUTE PSYCHOSIS
|
DISULFIRAM CAUSES ACUTE PSYCHOSIS
|
DISULFIRAM CAUSES ACUTE PSYCHOSIS
|
DISULFIRAM CAUSES ACUTE PSYCHOSIS
|
THEOPHYLLIN PLASMA CONCENTRATION IS RAISED BY THE DRUG
|
THEOPHYLLIN PLASMA CONCENTRATION IS RAISED BY THE DRUG
|
DISULFIRAM CAUSE NON-COMPETITIVE INHIBITION OF PHENYTOIN METABOLISM LEADING TO INCREASED PLASMA LEVELS AND INCREASED HALF LIFE
|
ISONIAZID MAY CAUSE ACUTE BEHAVIORAL & COORDINATION CHANGES IN THE PATIENT
|
DISULFIRAM MAY CAUSE ACUTE ORGANIC BRAIN SYNDROME
|
DISULFIRAM MAY CAUSE ACUTE ORGANIC BRAIN SYNDROME
|
DISULFIRAM MAY CAUSE ACUTE ORGANIC BRAIN SYNDROME
|
DISULFIRAM MAY CAUSE ACUTE ORGANIC BRAIN SYNDROME
|
DISULFIRAM MAY CAUSE ACUTE ORGANIC BRAIN SYNDROME
|
DISULFIRAM MAY CAUSE ACUTE ORGANIC BRAIN SYNDROME
|
DISULFIRAM MAY CAUSE ACUTE ORGANIC BRAIN SYNDROME
|
DISULFIRAM MAY CAUSE ACUTE ORGANIC BRAIN SYNDROME
|
DISULFIRAM MAY CAUSE ACUTE ORGANIC BRAIN SYNDROME
|
DISULFIRAM MAY CAUSE ACUTE ORGANIC BRAIN SYNDROME
|
DISULFIRAM MAY CAUSE ACUTE ORGANIC BRAIN SYNDROME
|
DISULFIRAM MAY CAUSE ACUTE ORGANIC BRAIN SYNDROME
|
DISULFIRAM CHRONIC TREATMENT MAY CAUSE REDUCED METABOLISM OF THE DRUG LEADING TO INCREASED PLASMA LEVELS & PROLONGED HALF LIFE OF THE DRUG
|
DISULFIRAM CHRONIC TREATMENT MAY CAUSE REDUCED METABOLISM OF THE DRUG LEADING TO INCREASED PLASMA LEVELS & PROLONGED HALF LIFE OF THE DRUG
|
DISULFIRAM CHRONIC TREATMENT MAY CAUSE REDUCED METABOLISM OF THE DRUG LEADING TO INCREASED PLASMA LEVELS & PROLONGED HALF LIFE OF THE DRUG
|
DISULFIRAM CHRONIC TREATMENT MAY CAUSE REDUCED METABOLISM OF THE DRUG LEADING TO INCREASED PLASMA LEVELS & PROLONGED HALF LIFE OF THE DRUG
|
DISULFIRAM CHRONIC TREATMENT MAY CAUSE REDUCED METABOLISM OF THE DRUG LEADING TO INCREASED PLASMA LEVELS & PROLONGED HALF LIFE OF THE DRUG
|
DISULFIRAM CHRONIC TREATMENT MAY CAUSE REDUCED METABOLISM OF THE DRUG LEADING TO INCREASED PLASMA LEVELS & PROLONGED HALF LIFE OF THE DRUG
|
DISULFIRAM CHRONIC TREATMENT MAY CAUSE REDUCED METABOLISM OF THE DRUG LEADING TO INCREASED PLASMA LEVELS & PROLONGED HALF LIFE OF THE DRUG
|
DISULFIRAM CHRONIC TREATMENT MAY CAUSE REDUCED METABOLISM OF THE DRUG LEADING TO INCREASED PLASMA LEVELS & PROLONGED HALF LIFE OF THE DRUG
|
DISULFIRAM CHRONIC TREATMENT MAY CAUSE REDUCED METABOLISM OF THE DRUG LEADING TO INCREASED PLASMA LEVELS & PROLONGED HALF LIFE OF THE DRUG
|
DISULFIRAM CHRONIC TREATMENT MAY CAUSE REDUCED METABOLISM OF THE DRUG LEADING TO INCREASED PLASMA LEVELS & PROLONGED HALF LIFE OF THE DRUG
|
DISULFIRAM CHRONIC TREATMENT MAY CAUSE REDUCED METABOLISM OF THE DRUG LEADING TO INCREASED PLASMA LEVELS & PROLONGED HALF LIFE OF THE DRUG
|
DISULFIRAM CHRONIC TREATMENT MAY CAUSE REDUCED METABOLISM OF THE DRUG LEADING TO INCREASED PLASMA LEVELS & PROLONGED HALF LIFE OF THE DRUG
|
DISULFIRAM CHRONIC TREATMENT MAY CAUSE REDUCED METABOLISM OF THE DRUG LEADING TO INCREASED PLASMA LEVELS & PROLONGED HALF LIFE OF THE DRUG
|
DISULFIRAM CHRONIC TREATMENT MAY CAUSE REDUCED METABOLISM OF THE DRUG LEADING TO INCREASED PLASMA LEVELS & PROLONGED HALF LIFE OF THE DRUG
|
DISULFIRAM CHRONIC TREATMENT MAY CAUSE REDUCED METABOLISM OF THE DRUG LEADING TO INCREASED PLASMA LEVELS & PROLONGED HALF LIFE OF THE DRUG
|
DISULFIRAM CHRONIC TREATMENT MAY CAUSE REDUCED METABOLISM OF THE DRUG LEADING TO INCREASED PLASMA LEVELS & PROLONGED HALF LIFE OF THE DRUG
|
DISULFIRAM CHRONIC TREATMENT MAY CAUSE REDUCED METABOLISM OF THE DRUG LEADING TO INCREASED PLASMA LEVELS & PROLONGED HALF LIFE OF THE DRUG
|
DISULFIRAM CHRONIC TREATMENT MAY CAUSE REDUCED METABOLISM OF THE DRUG LEADING TO INCREASED PLASMA LEVELS & PROLONGED HALF LIFE OF THE DRUG
|
DISULFIRAM CHRONIC TREATMENT MAY CAUSE REDUCED METABOLISM OF THE DRUG LEADING TO INCREASED PLASMA LEVELS & PROLONGED HALF LIFE OF THE DRUG
|
DISULFIRAM CHRONIC TREATMENT MAY CAUSE REDUCED METABOLISM OF THE DRUG LEADING TO INCREASED PLASMA LEVELS & PROLONGED HALF LIFE OF THE DRUG
|
INCREASED CHANCES OF PERIPHERAL NEUROPATHY
|